JWH 122 N-(4-hydroxypentyl) metabolite – 5 mg

Brand:
Cayman
CAS:
1537889-07-8
Storage:
-20
UN-No:
Non-Hazardous - 2811 / 6.1

JWH 122 is a synthetic cannabinoid (CB) that displays high affinities for both the central CB1 receptor (Ki = 0.69 nM) and the peripheral CB2 receptor (Ki = 1.2 nM).{18232,16684} JWH 122 N-(4-hydroxypentyl) metabolite is an expected phase I metabolite of JWH 122, detectable in serum and urine. While similar hydroxylated phase I metabolites of synthetic cannabinoids retain activity, the physiological properties of this compound have yet to be determined.{20952,20953} This product is intended for research and forensic applications.  

 

Available on backorder

SKU: 11784 - 5 mg Category:

Description

An expected phase I metabolite of JWH 122, detectable in serum and urine; intended for research and forensic applications


Formal name: (1-(4-hydroxypentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

Synonyms: 

Molecular weight: 371.5

CAS: 1537889-07-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Drugs of Abuse||Research Area|Forensic Chemistry & Toxicology|Cannabinoids|Synthetic Cannabinoids